1. Home
  2. Analysis
  3. Mycophenolate-mofetil
  4. Cabometyx

Mycophenolate mofetil and Cabometyx drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mycophenolate mofetil (mycophenolate mofetil) and Cabometyx (cabozantinib s-malate). Common drug interactions include alopecia among females and rash among males.

The phase IV clinical study analyzes what interactions people have when they take Mycophenolate mofetil and Cabometyx. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,460 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

What is Cabometyx?

Cabometyx has active ingredients of cabozantinib s-malate. eHealthMe is studying from 35,069 Cabometyx users. Check the latest studies of Cabometyx.

On Jul, 14, 2026

22 people who take Mycophenolate mofetil and Cabometyx together, and have interactions are studied.

Mycophenolate mofetil and Cabometyx drug interactions.

What are the common drug interactions of Mycophenolate Mofetil and Cabometyx, by gender? *:

female:

  1. Alopecia (absence of hair from areas of the body)
  2. Constipation
  3. Fatigue (feeling of tiredness)
  4. Decreased appetite
  5. Vomiting
  6. Hepatic enzyme increased
  7. Dysphonia (speech disorder attributable to a disorder of phonation)
  8. Gingival ulceration (ulcer on gums)
  9. Hypertension (high blood pressure)
  10. Joint stiffness

male:

  1. Rash
  2. Liver disorder (liver diseases)
  3. Death
  4. Drug ineffective
  5. Dry skin
  6. Headache (pain in head)
  7. Metastases to bone (cancer spreads to bone)
  8. Nausea (feeling of having an urge to vomit)
  9. Oral mucosal blistering (mouth ulcer)
  10. Oropharyngeal pain

What are the common drug interactions of Mycophenolate Mofetil and Cabometyx, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Metastases to bone (cancer spreads to bone)

50-59:

  1. Alopecia (absence of hair from areas of the body)
  2. Constipation
  3. Decreased appetite
  4. Dysphonia (speech disorder attributable to a disorder of phonation)
  5. Fatigue (feeling of tiredness)
  6. Gingival ulceration (ulcer on gums)
  7. Hepatic enzyme increased
  8. Hypertension (high blood pressure)
  9. Joint stiffness
  10. Nausea (feeling of having an urge to vomit)

60+:

  1. Weight decreased
  2. Abdominal discomfort
  3. Abdominal pain upper
  4. Blood pressure increased
  5. Death
  6. Asthenia (weakness)
  7. Decreased appetite
  8. Diarrhoea
  9. Pulmonary embolism (blockage of the main artery of the lung)
  10. Secretion discharge

What are the existing conditions these people have? *

  1. Renal Cell Carcinoma (a kidney cancer): 20 people, 90.91%
  2. Metastases To Bone (cancer spreads to bone): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and Cabometyx?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mycophenolate mofetil and Cabometyx:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mycophenolate mofetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cabometyx:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mycophenolate mofetil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cabometyx and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil and cabozantinib s-malate (the active ingredients of Mycophenolate mofetil and Cabometyx, respectively), and Mycophenolate mofetil and Cabometyx (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.